Similar articles

• Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial.

  D'Amico AV, Roehrborn CG. D'Amico AV, et al. Lancet Oncol. 2007 Jan;8(1):21-5. doi: 10.1016/S1470-2045(06)70981-0. Lancet Oncol. 2007. PMID: 17196507 Clinical Trial.
• Value of hormonal levels in patients with male androgenetic alopecia treated with finasteride: better response in patients under 26 years old.

  Camacho FM, García-Hernández MJ, Fernández-Crehuet JL. Camacho FM, et al. Br J Dermatol. 2008 May;158(5):1121-4. doi: 10.1111/j.1365-2133.2008.08509.x. Epub 2008 Mar 20. Br J Dermatol. 2008. PMID: 18363752
• Selections from current literature: androgenetic alopecia: the science behind a new oral treatment.

  Baumann LS, Kelso EB. Baumann LS, et al. Fam Pract. 1998 Oct;15(5):493-6. doi: 10.1093/fampra/15.5.493. Fam Pract. 1998. PMID: 9848437 Review. No abstract available.
• Change in Prostate Specific Antigen Concentration in Men with Prostate Specific Antigen Less than 2.5 ng/ml Taking Low Dose Finasteride or Dutasteride for Male Androgenetic Alopecia.

  Kang HW, Chae MH, Park SH, Seo SP, Kim WT, Kim YJ, Yun SJ, Lee SC, Yoon TY, Kim WJ. Kang HW, et al. J Urol. 2017 Dec;198(6):1340-1345. doi: 10.1016/j.juro.2017.07.075. Epub 2017 Jul 23. J Urol. 2017. PMID: 28743526
• [Finasteride: a new drug for the treatment of male hirsutism and androgenetic alopecia?].

  Spinucci G, Pasquali R. Spinucci G, et al. Clin Ter. 1996 Jun;147(6):305-15. Clin Ter. 1996. PMID: 8925640 Review. Italian.